| http://www.w3.org/ns/prov#value | - MANCHESTER, NH--(Marketwire - June 07, 2012) - Highlighted Links http://www.bostonti.com http://sugardown.com Boston Therapeutics, Inc. (OTCQB: BTHE) (OTCBB: BTHE) (Boston Therapeutics" or the Company), a developer of complex carbohydrates to treat diabetes and other inflammatory diseases, today announced it has secured eligibility by The Depository Trust Company (DTC) for its shares on the OTC
|
